Tri-sprintec Kit
Product Images NDC 68788-6325

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tri-sprintec (NDC 68788-6325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4410ea34 8a24 4316 8658 431a13e02e46 00

Tri-Sprintec (norgestimate and ethinyl estradiol) tablet packaging label. The label includes the brand and generic names, highlights it as a generic for Ortho Tri-Cyclen 28 Day, and displays manufacturer Teva Pharmaceuticals USA Inc. It features dosage directions in English and Spanish, a barcode, and legal cautionary text regarding drug transfer restrictions. The label is mostly white with yellow sections for directions.*

FDA Label Image

Image 1

Tri-Sprintec is a 28-day oral tablet kit containing norgestimate and ethinyl estradiol. The image shows a blister pack with four rows of seven circular tablets, each row labeled for a different week (Week 1 to Week 4) and days of the week (Sunday to Saturday) across the top. Tablets vary in shading to indicate different types or active ingredients. Instructions indicate taking all colored pills before the white pills. The label includes storage instructions and the designation Rx only. The product is labeled by Preferred Pharmaceuticals Inc.*

FDA Label Image

Image 2

Chemical structure of norgestimate, USP, the active ingredient in Tri-Sprintec. The diagram shows the molecular layout including functional groups and bonds of norgestimate as labeled in the image.*

FDA Label Image

Image 3

Chemical structure of ethinyl estradiol, USP, depicting the molecular arrangement of atoms including hydroxyl groups and ethynyl substitution, as shown in the diagram.*

FDA Label Image

Image 4

A diagram illustrating pregnancy prevention effectiveness of various birth control methods. It features a vertical arrow with 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom. Methods range from sterilization, implants, injections, intrauterine devices, and birth control pills at the top, to no birth control at the bottom. The diagram categorizes effectiveness with approximate pregnancy rates per 100 women per year on the left.*

FDA Label Image

Image 5

Tri-Sprintec kit contains norgestimate and ethinyl estradiol tablets USP arranged in a 28-day blister pack. The pack is organized by day of the week and divided into four rows labeled Week 1 through Week 4 with colored pills: light gray in Week 1, white in Week 2, dark gray in Week 3, and white in Week 4. Instructions indicate to take all colored pills before any white pills. Storage is specified at 20° to 25°C (68° to 77°F). The labeler is Preferred Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.